Although Act1 is necessary for IL-17-mediated inflammatory responses, Act1-deficient mice develop spontaneous inflammatory/autoimmune diseases, including hypergammaglobulinemia, elevated serum autoantibodies, SLE-like nephritis, and Sjögren’s-like disease3–6. This evidence concerns the gene TRAF3IP2 and systemic lupus erythematosus.